期刊文献+

新型心肌灌注显像剂^(99)Tc^m-N-DBODC5在兔体内的生物分布

Study of Biodistribution Properties of a New Myocardial Imaging Agent ^(99)Tc^m-N-DBODC5
下载PDF
导出
摘要 制备了99Tcm-N-DBODC5,并将其经静脉注射到新西兰白兔体内,进行活体显像,检测其活体生物分布及离体器官分布,研究99Tcm-N-DBODC5作为心肌灌注显像剂的可行性。活体生物分布结果显示,99Tcm-N-DBODC5的心肌摄取迅速,心肌摄取量低于99Tcm-MIBI,99Tcm-N-DBODC5的肝清除速度显著快于99Tcm-MIBI,在注射后30 min时心与肝的T/NT为0.98±0.52,已接近1,显著高于99Tcm-MIBI的心与肝的T/NT(0.56±0.19),P=0.007。60 min时,99Tcm-N-DBODC5的心与肝的T/NT达到高峰,为1.18±0.57,而99Tcm-MIBI仅为0.71±0.29。在180 min内,99Tcm-N-DBODC5的心与肝的T/NT维持在较高水平9。9Tcm-N-DBODC5的肺摄取低,清除快,心与肺的T/NT在180 min内保持在1.43±0.37以上,与99Tcm-MIBI无显著差别9。9Tcm-N-DBODC5的肝清除迅速,避免了肝内放射性对左室下壁的干扰,有利于实现早期显像。故99Tcm-N-DBODC有望成为一种生物分布特性较好的新的心肌灌注显像剂。 ^99Tc^m-N-DBODC5 for intravenous injection was prepared. The labelling yield was 95.0% ±0. 52%. Sixteen New Zealand rabbits were involved and planar gamma imaging was performed at 10 time-point after injection of ^99Tc^m-N-DBODC5. The radioactivity changes of organs were calculated by regions of interest (ROD analysis. The 16 rabbits were divided into 4 groups and were sacrificed at 30, 60, 120, and 180 min after injection respectively. The activity for all excised organs were measured by 7-well counting for calculating radiouptake. Myocardial uptake for ^99Tc^m-N-DBODC5 is high. Though myocardial uptake was lower than ^99Tc^m-MIBI, the liver clearance for ^99Tc^m-N-DBODC5 was more rapid than that of ^99Tc^m-MIBI. As early as 30 min after injection, ^99Tc^m-N-DBODC5 heart-to-liver ratio is 0.98±0.52 versus 0. 56±0.19 for ^99Tc^m-MIBI (P〈0.01). At 60 min post-injection, ^99Tc^m-N-DBODC5 heart-to-liver ratio improved to the peak value (1.18±0.57), compared with 0.71±0.29 for ^99Tc^m-MIBI, P〈0.01. After 60 min, the heart-to-liver ratio of ^99Tc^m-N-DBODC5 was keeping at a high level until 180 min. ^99Tc^m-N-DBODC5 exhibited rapid lung clearance, similar to that of ^99Tc^m-MIBI. The biodistribution in the isolated organs demonstrated the same trend. The rapid ^99Tc^m-N-DBODC5 liver clearance may allow the earlier imaging, and overcome the photon scatter from the liver with high activity which interfered the inferoapical wall in myocardial images. ^99Tc^m-N-DBODC5 is a promising new myocardial perfusion imaging agent with superior biodistribution properties.
出处 《同位素》 CAS 北大核心 2007年第4期199-205,共7页 Journal of Isotopes
关键词 ^99Tc^m-—DBODC5 生物分布 肝清除 心肌灌注显像剂 ^99Tc^m-N-DBODC5 biodistribution liver clearance myocardial perfusion tracer
  • 相关文献

参考文献12

  • 1BELLER GA, WATSON DD. Physiological Basis of Myocardial Perfusion Imaging With the Technetium 99m Agent [J]. Semin Nuel Med, 1991, 21: 173-181.
  • 2KELLY JD, FORSTER AM, HIGLEY B, et al.Technetium-99m-tetrofosmin as a New Radiopharmaceutical for Myocardial Perfusion Imaging [J]. J Nucl Med, 1993, 34: 222-227.
  • 3NAKAJIMA K, TAKI J, SHUKE N, et al. Myocardial Perfusion Imaging and Dynamic Analysis With Technetium-99m Tetrofosmin [J]. J Nucl Med, 1993, 34:1 478-1 484.
  • 4BOSCHI A, BOLZATI C, UCCELLI L, et al. A Class of Asymmetrical Nitride 99Tcm_Heterocomplexes as Hear Imaging Agents With Improved Biological Properties [ J]. Nucl Med Commun, 2002, 23: 689-693.
  • 5BOSCHI A, UCCELLI L, BOLZATI C, et al. Synthesis and Biologic Evaluation of Monocationic Asymmetric ^99Tc^m-nitride H eterocomplexes Showing High Heart Uptake and Improved Imaging Properties [J]. J Nucl Med, 2003, 44: 806- 814.
  • 6HATADA K, RIOU LM, RUIZ M, et al. ^99Tc^m- N-DBODC5, A New Myocardial Perfusion Imaging Agent With Rapid Liver Clearance: Comparison With ^99 Tc^m-sestamibi and ^99Tc^m-tetrofosmin in Rats [J]. J Nucl Med, 2004, 45:9 095-2 101.
  • 7楚进锋,孔德靖,李彬,王学斌,陆洁,王金城,米宏志,赵建冬.^(99m)TcN核标记的新型心肌灌注显像剂的研究[J].高等学校化学学报,2006,27(6):1016-1019. 被引量:4
  • 8楚进锋,李彬,孔德靖,王学斌,张俊波,王金城,米宏志,赵建冬.[^(99)mTcN(PNP5)(NOEt)]^+新型心肌灌注显像剂研究[J].高等学校化学学报,2005,26(6):1014-1017. 被引量:7
  • 9楚进锋,李彬,孔德靖,王学斌,张俊波.新型^(99m)TcN核混配配合物的制备和小鼠生物分布[J].北京师范大学学报(自然科学版),2006,42(5):514-517. 被引量:3
  • 10LEPPO JA, DEPUCY EG, JOHNSON LL. A Review of Cardiac Imaging With Sestamibi and Teboroxime [J]. J Nucl Med, 1991, 32:2 012- 2 022.

二级参考文献23

  • 1楚进锋,李彬,孔德靖,王学斌,张俊波,王金城,米宏志,赵建冬.[^(99)mTcN(PNP5)(NOEt)]^+新型心肌灌注显像剂研究[J].高等学校化学学报,2005,26(6):1014-1017. 被引量:7
  • 2Parker J. A.. Sem. Nucl. Med.[J], 2001, 31(3): 223-237.
  • 3Duatti A., Bolzati C., Uccelli L. et al.. EP 0 949 265[P], 1999.
  • 4Boschi A., Bolzati C., Uccelli L. et al.. Nucl. Med. Commun.[J], 2002, 23(7): 689-693.
  • 5Boschi A., Uccelli L., Bolzati C. et al.. J. Nucl. Med.[J], 2003, 44(5): 806-814.
  • 6Duatti A., Bolzati C., Uccelli L. et al.. WO 02/09 771[P], 2002.
  • 7Bolzati C., Boschi A., Uccelli L. et al.. J. Am. Chem. Soc.[J], 2002, 124(38): 11468-11479.
  • 8Bianchini C., Farnetti E., Glendenning L. et al.. Organometallics[J], 1995, 14(3): 1489-1502.
  • 9张现忠.[D].Beijing Normal University,2002.
  • 10Duatti A. , Bolzati C. , Uccelli L. et al.. EP 0949265[P] , 1999

共引文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部